Urolithin A Side Effects: What the Trials Reported

Most supplement "side effect" pages are an exercise in either fearmongering or false reassurance, because for most ingredients there simply isn't real safety data to report. Urolithin A is, again, one of the rare exceptions: it's been put through actual randomized, placebo-controlled human trials in which adverse events were tracked and reported. So instead of guessing, we can say what the studies actually found. The honest headline is genuinely good news — urolithin A has been well tolerated in the human work to date, with no significant adverse-event signal versus placebo at the tested doses. But "well tolerated so far" is not the same as "proven safe forever," and this page draws that line carefully.

For the full benefits-and-evidence picture, start with our urolithin A evidence review; for how much the trials used, see our urolithin A dosage page. This page is narrowly about safety and side effects.

What "well tolerated" actually means here

Tolerability isn't a vibe — in a trial it's a measured outcome. Researchers track adverse events in both the treatment and placebo groups and compare. For urolithin A, the standout finding across the human studies is the absence of a meaningful safety signal.

The first-in-human study is the anchor. It established that oral urolithin A is safe and bioavailable, and that it induced a molecular signature of improved mitochondrial and cellular health in older adults — explicitly without serious adverse events at the doses tested ¹. That's an unusually clean result for a supplement ingredient, and it's the single most important piece of the safety case.

The two randomized controlled trials that carry urolithin A's functional case reinforce the same picture. In middle-aged adults, urolithin A improved muscle strength and some exercise-performance and mitochondrial biomarkers versus placebo — and was reported as well tolerated ². In older adults, a randomized trial found improvements in muscle endurance and mitochondrial-health markers, again with good tolerability and no significant adverse-event signal relative to placebo ³. Across all three studies, the consistent message is the same: at trial doses, the molecule didn't produce a worrying side-effect profile.

The side effects that have been reported

"Well tolerated" does not mean "literally zero effects in anyone." In supplement and trial settings, the issues people occasionally report with urolithin A are mild and gastrointestinal — the sort of transient digestive complaints (such as mild stomach upset) that accompany many oral supplements, particularly when starting one. Crucially, in the controlled trials these did not separate meaningfully from what the placebo groups experienced, which is exactly why the studies describe it as well tolerated rather than flagging a specific adverse effect ²³.

If you do start urolithin A and notice mild digestive upset, taking it with food is the standard, sensible first move — the trials dosed it with food anyway, and it tends to settle as your system adjusts. Anything beyond mild and transient is a reason to stop and reassess rather than push through.

The honest limits: why "so far" is doing real work

Here's where the evidence-first framing matters. The clean tolerability record is real, but it comes with boundaries that the marketing tends to skip:

• •The data are short-term. The human trials ran weeks to months, not years. A months-long study can characterize short-term tolerability well, but it cannot establish what daily use over many years does. Very-long-term safety is therefore not fully established — not because there's a red flag, but because the studies to answer it haven't been run.
• •It's a relatively new postbiotic. Urolithin A as a supplement is recent. It doesn't have the decades-long, population-scale track record that something like fiber or a long-marketed vitamin carries. A short trial record plus novelty means a smaller total base of safety experience.
• •Modest trial sizes. The studies are genuine RCTs, but they're moderate in size. Rare side effects — the kind that only show up across tens of thousands of users — wouldn't necessarily appear in trials of this scale.
• •Special populations weren't studied. Pregnancy, breastfeeding, and people on medication or with medical conditions weren't included, so there's no safety data for them, and no basis to assume the reassuring tolerability extends to those groups.

None of this is a reason for alarm. It's the difference between "the available human evidence looks reassuring" and "proven safe under all conditions for everyone indefinitely" — and an honest page won't let the first quietly become the second.

Who should be cautious

Even with a clean short-term record, a few groups should not extrapolate from it. Pregnant or breastfeeding people weren't studied and should not use it absent clinician guidance. Anyone taking medications or managing a health condition should check with a clinician before starting, since interactions and effects in those contexts simply haven't been tested. And anyone who experiences more than mild, transient digestive upset should stop and consult a professional rather than assume the trial-grade tolerability applies to them.

The honest bottom line

Urolithin A has something most supplements can't offer: an actual human safety record, and a reassuring one. Across a first-in-human study and two randomized controlled trials, it was well tolerated, with no significant adverse-event signal versus placebo and only mild, transient gastrointestinal complaints when anything was reported at all ¹²³. That's genuinely good news for a supplement. The honest caveat is scope, not safety: the data are short-term, the sample sizes modest, the ingredient relatively new, and special populations unstudied — so "well tolerated so far" is the accurate claim, not "proven safe forever." If you've decided to buy, our best urolithin A supplement roundup covers which products match the tested form, and for where it sits among gut-derived compounds see our best gut health supplements hub. To run the numbers on a stated dose, our tools can help.